IL10 and rheumatoid arthritis: The addition of adalimumab to the culture decreased the concentrations of all the studied cytokines, reaching significant values for IFN-γ, TNF-α, and IL-10 compared to the HCs and for this latter cytokine compared to untreated PBMCs from RA patients.